aluates Reports

$ 0.0

Automative

Global Non-invasive Helicobacter Pylori Diagnostic Market Research Report 2024

Published Date: May 2024

Report Code: QYRE-Auto-18R11421

Global Non invasive Helicobacter Pylori Diagnostic Market Research Report 2022

BUY CHAPTERS

Global Non-invasive Helicobacter Pylori Diagnostic Market Research Report 2024

Code: QYRE-Auto-18R11421

Report

May 2024

Pages:87

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Sekisui Diagnostics

F.Hoffmann-La Roche

Medline Industries

Meridian Bioscience

Bio Rad Laboratories

Thermo Fisher Scientific

Alpha Laboratories

EKF Diagnostics

Quidel

Halyard Health

Cardinal Health

Beckman Coulter

Agilent Technologies

Coris BioConcept

Non-invasive Helicobacter Pylori Diagnostic Market Size

The global Non-invasive Helicobacter Pylori Diagnostic market was valued at US$ 510.4 million in 2023 and is anticipated to reach US$ 642.9 million by 2030, witnessing a CAGR of 3.4% during the forecast period 2024-2030.

Non-invasive Helicobacter Pylori Diagnostic Market

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Non-invasive Helicobacter Pylori Diagnostic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Non-invasive Helicobacter Pylori Diagnostic.

Report Scope

The Non-invasive Helicobacter Pylori Diagnostic market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Non-invasive Helicobacter Pylori Diagnostic market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Non-invasive Helicobacter Pylori Diagnostic companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Non-invasive Helicobacter Pylori Diagnostic Market Report

Report Metric	Details
Report Name	Non-invasive Helicobacter Pylori Diagnostic Market
Accounted market size in 2023	US$ 510.4 million
Forecasted market size in 2030	US$ 642.9 million
CAGR	3.4%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Invasive Techniques Non-invasive Techniques
Segment by Application	Hospitals and Clinics Diagnostic Laboratories
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Sekisui Diagnostics, F. Hoffmann-La Roche, Medline Industries, Meridian Bioscience, Bio-Rad Laboratories, Thermo Fisher Scientific, Alpha Laboratories, EKF Diagnostics, Quidel, Halyard Health, Cardinal Health, Beckman Coulter, Agilent Technologies, Coris BioConcept
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Non-invasive Helicobacter Pylori Diagnostic companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Non-invasive Helicobacter Pylori Diagnostic Market growing?

Ans: The Non-invasive Helicobacter Pylori Diagnostic Market witnessing a CAGR of 3.4% during the forecast period 2024-2030.

What is the Non-invasive Helicobacter Pylori Diagnostic Market size in 2030?

Ans: The Non-invasive Helicobacter Pylori Diagnostic Market size in 2030 will be US$ 642.9 million.

Who are the main players in the Non-invasive Helicobacter Pylori Diagnostic Market report?

Ans: The main players in the Non-invasive Helicobacter Pylori Diagnostic Market are Sekisui Diagnostics, F. Hoffmann-La Roche, Medline Industries, Meridian Bioscience, Bio-Rad Laboratories, Thermo Fisher Scientific, Alpha Laboratories, EKF Diagnostics, Quidel, Halyard Health, Cardinal Health, Beckman Coulter, Agilent Technologies, Coris BioConcept

What are the Application segmentation covered in the Non-invasive Helicobacter Pylori Diagnostic Market report?

Ans: The Applications covered in the Non-invasive Helicobacter Pylori Diagnostic Market report are Hospitals and Clinics, Diagnostic Laboratories

What are the Type segmentation covered in the Non-invasive Helicobacter Pylori Diagnostic Market report?

Ans: The Types covered in the Non-invasive Helicobacter Pylori Diagnostic Market report are Invasive Techniques, Non-invasive Techniques

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Non-invasive Helicobacter Pylori Diagnostic Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Invasive Techniques

1.2.3 Non-invasive Techniques

1.3 Market by Application

1.3.1 Global Non-invasive Helicobacter Pylori Diagnostic Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Hospitals and Clinics

1.3.3 Diagnostic Laboratories

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Non-invasive Helicobacter Pylori Diagnostic Market Perspective (2019-2030)

2.2 Non-invasive Helicobacter Pylori Diagnostic Growth Trends by Region

2.2.1 Global Non-invasive Helicobacter Pylori Diagnostic Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Non-invasive Helicobacter Pylori Diagnostic Historic Market Size by Region (2019-2024)

2.2.3 Non-invasive Helicobacter Pylori Diagnostic Forecasted Market Size by Region (2025-2030)

2.3 Non-invasive Helicobacter Pylori Diagnostic Market Dynamics

2.3.1 Non-invasive Helicobacter Pylori Diagnostic Industry Trends

2.3.2 Non-invasive Helicobacter Pylori Diagnostic Market Drivers

2.3.3 Non-invasive Helicobacter Pylori Diagnostic Market Challenges

2.3.4 Non-invasive Helicobacter Pylori Diagnostic Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Non-invasive Helicobacter Pylori Diagnostic Players by Revenue

3.1.1 Global Top Non-invasive Helicobacter Pylori Diagnostic Players by Revenue (2019-2024)

3.1.2 Global Non-invasive Helicobacter Pylori Diagnostic Revenue Market Share by Players (2019-2024)

3.2 Global Non-invasive Helicobacter Pylori Diagnostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Non-invasive Helicobacter Pylori Diagnostic Revenue

3.4 Global Non-invasive Helicobacter Pylori Diagnostic Market Concentration Ratio

3.4.1 Global Non-invasive Helicobacter Pylori Diagnostic Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Non-invasive Helicobacter Pylori Diagnostic Revenue in 2023

3.5 Non-invasive Helicobacter Pylori Diagnostic Key Players Head office and Area Served

3.6 Key Players Non-invasive Helicobacter Pylori Diagnostic Product Solution and Service

3.7 Date of Enter into Non-invasive Helicobacter Pylori Diagnostic Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Non-invasive Helicobacter Pylori Diagnostic Breakdown Data by Type

4.1 Global Non-invasive Helicobacter Pylori Diagnostic Historic Market Size by Type (2019-2024)

4.2 Global Non-invasive Helicobacter Pylori Diagnostic Forecasted Market Size by Type (2025-2030)

5 Non-invasive Helicobacter Pylori Diagnostic Breakdown Data by Application

5.1 Global Non-invasive Helicobacter Pylori Diagnostic Historic Market Size by Application (2019-2024)

5.2 Global Non-invasive Helicobacter Pylori Diagnostic Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Non-invasive Helicobacter Pylori Diagnostic Market Size (2019-2030)

6.2 North America Non-invasive Helicobacter Pylori Diagnostic Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Non-invasive Helicobacter Pylori Diagnostic Market Size by Country (2019-2024)

6.4 North America Non-invasive Helicobacter Pylori Diagnostic Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Non-invasive Helicobacter Pylori Diagnostic Market Size (2019-2030)

7.2 Europe Non-invasive Helicobacter Pylori Diagnostic Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Non-invasive Helicobacter Pylori Diagnostic Market Size by Country (2019-2024)

7.4 Europe Non-invasive Helicobacter Pylori Diagnostic Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Non-invasive Helicobacter Pylori Diagnostic Market Size (2019-2030)

8.2 Asia-Pacific Non-invasive Helicobacter Pylori Diagnostic Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Non-invasive Helicobacter Pylori Diagnostic Market Size by Region (2019-2024)

8.4 Asia-Pacific Non-invasive Helicobacter Pylori Diagnostic Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Non-invasive Helicobacter Pylori Diagnostic Market Size (2019-2030)

9.2 Latin America Non-invasive Helicobacter Pylori Diagnostic Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Non-invasive Helicobacter Pylori Diagnostic Market Size by Country (2019-2024)

9.4 Latin America Non-invasive Helicobacter Pylori Diagnostic Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Non-invasive Helicobacter Pylori Diagnostic Market Size (2019-2030)

10.2 Middle East & Africa Non-invasive Helicobacter Pylori Diagnostic Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Non-invasive Helicobacter Pylori Diagnostic Market Size by Country (2019-2024)

10.4 Middle East & Africa Non-invasive Helicobacter Pylori Diagnostic Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Sekisui Diagnostics

11.1.1 Sekisui Diagnostics Company Detail

11.1.2 Sekisui Diagnostics Business Overview

11.1.3 Sekisui Diagnostics Non-invasive Helicobacter Pylori Diagnostic Introduction

11.1.4 Sekisui Diagnostics Revenue in Non-invasive Helicobacter Pylori Diagnostic Business (2019-2024)

11.1.5 Sekisui Diagnostics Recent Development

11.2 F. Hoffmann-La Roche

11.2.1 F. Hoffmann-La Roche Company Detail

11.2.2 F. Hoffmann-La Roche Business Overview

11.2.3 F. Hoffmann-La Roche Non-invasive Helicobacter Pylori Diagnostic Introduction

11.2.4 F. Hoffmann-La Roche Revenue in Non-invasive Helicobacter Pylori Diagnostic Business (2019-2024)

11.2.5 F. Hoffmann-La Roche Recent Development

11.3 Medline Industries

11.3.1 Medline Industries Company Detail

11.3.2 Medline Industries Business Overview

11.3.3 Medline Industries Non-invasive Helicobacter Pylori Diagnostic Introduction

11.3.4 Medline Industries Revenue in Non-invasive Helicobacter Pylori Diagnostic Business (2019-2024)

11.3.5 Medline Industries Recent Development

11.4 Meridian Bioscience

11.4.1 Meridian Bioscience Company Detail

11.4.2 Meridian Bioscience Business Overview

11.4.3 Meridian Bioscience Non-invasive Helicobacter Pylori Diagnostic Introduction

11.4.4 Meridian Bioscience Revenue in Non-invasive Helicobacter Pylori Diagnostic Business (2019-2024)

11.4.5 Meridian Bioscience Recent Development

11.5 Bio-Rad Laboratories

11.5.1 Bio-Rad Laboratories Company Detail

11.5.2 Bio-Rad Laboratories Business Overview

11.5.3 Bio-Rad Laboratories Non-invasive Helicobacter Pylori Diagnostic Introduction

11.5.4 Bio-Rad Laboratories Revenue in Non-invasive Helicobacter Pylori Diagnostic Business (2019-2024)

11.5.5 Bio-Rad Laboratories Recent Development

11.6 Thermo Fisher Scientific

11.6.1 Thermo Fisher Scientific Company Detail

11.6.2 Thermo Fisher Scientific Business Overview

11.6.3 Thermo Fisher Scientific Non-invasive Helicobacter Pylori Diagnostic Introduction

11.6.4 Thermo Fisher Scientific Revenue in Non-invasive Helicobacter Pylori Diagnostic Business (2019-2024)

11.6.5 Thermo Fisher Scientific Recent Development

11.7 Alpha Laboratories

11.7.1 Alpha Laboratories Company Detail

11.7.2 Alpha Laboratories Business Overview

11.7.3 Alpha Laboratories Non-invasive Helicobacter Pylori Diagnostic Introduction

11.7.4 Alpha Laboratories Revenue in Non-invasive Helicobacter Pylori Diagnostic Business (2019-2024)

11.7.5 Alpha Laboratories Recent Development

11.8 EKF Diagnostics

11.8.1 EKF Diagnostics Company Detail

11.8.2 EKF Diagnostics Business Overview

11.8.3 EKF Diagnostics Non-invasive Helicobacter Pylori Diagnostic Introduction

11.8.4 EKF Diagnostics Revenue in Non-invasive Helicobacter Pylori Diagnostic Business (2019-2024)

11.8.5 EKF Diagnostics Recent Development

11.9 Quidel

11.9.1 Quidel Company Detail

11.9.2 Quidel Business Overview

11.9.3 Quidel Non-invasive Helicobacter Pylori Diagnostic Introduction

11.9.4 Quidel Revenue in Non-invasive Helicobacter Pylori Diagnostic Business (2019-2024)

11.9.5 Quidel Recent Development

11.10 Halyard Health

11.10.1 Halyard Health Company Detail

11.10.2 Halyard Health Business Overview

11.10.3 Halyard Health Non-invasive Helicobacter Pylori Diagnostic Introduction

11.10.4 Halyard Health Revenue in Non-invasive Helicobacter Pylori Diagnostic Business (2019-2024)

11.10.5 Halyard Health Recent Development

11.11 Cardinal Health

11.11.1 Cardinal Health Company Detail

11.11.2 Cardinal Health Business Overview

11.11.3 Cardinal Health Non-invasive Helicobacter Pylori Diagnostic Introduction

11.11.4 Cardinal Health Revenue in Non-invasive Helicobacter Pylori Diagnostic Business (2019-2024)

11.11.5 Cardinal Health Recent Development

11.12 Beckman Coulter

11.12.1 Beckman Coulter Company Detail

11.12.2 Beckman Coulter Business Overview

11.12.3 Beckman Coulter Non-invasive Helicobacter Pylori Diagnostic Introduction

11.12.4 Beckman Coulter Revenue in Non-invasive Helicobacter Pylori Diagnostic Business (2019-2024)

11.12.5 Beckman Coulter Recent Development

11.13 Agilent Technologies

11.13.1 Agilent Technologies Company Detail

11.13.2 Agilent Technologies Business Overview

11.13.3 Agilent Technologies Non-invasive Helicobacter Pylori Diagnostic Introduction

11.13.4 Agilent Technologies Revenue in Non-invasive Helicobacter Pylori Diagnostic Business (2019-2024)

11.13.5 Agilent Technologies Recent Development

11.14 Coris BioConcept

11.14.1 Coris BioConcept Company Detail

11.14.2 Coris BioConcept Business Overview

11.14.3 Coris BioConcept Non-invasive Helicobacter Pylori Diagnostic Introduction

11.14.4 Coris BioConcept Revenue in Non-invasive Helicobacter Pylori Diagnostic Business (2019-2024)

11.14.5 Coris BioConcept Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Sekisui Diagnostics

F.Hoffmann-La Roche

Medline Industries

Meridian Bioscience

Bio Rad Laboratories

Thermo Fisher Scientific

Alpha Laboratories

EKF Diagnostics

Quidel

Halyard Health

Cardinal Health

Beckman Coulter

Agilent Technologies

Coris BioConcept

List of Tables

Table 1. Global Non-invasive Helicobacter Pylori Diagnostic Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Invasive Techniques

Table 3. Key Players of Non-invasive Techniques

Table 4. Global Non-invasive Helicobacter Pylori Diagnostic Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 5. Global Non-invasive Helicobacter Pylori Diagnostic Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Non-invasive Helicobacter Pylori Diagnostic Market Size by Region (2019-2024) & (US$ Million)

Table 7. Global Non-invasive Helicobacter Pylori Diagnostic Market Share by Region (2019-2024)

Table 8. Global Non-invasive Helicobacter Pylori Diagnostic Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 9. Global Non-invasive Helicobacter Pylori Diagnostic Market Share by Region (2025-2030)

Table 10. Non-invasive Helicobacter Pylori Diagnostic Market Trends

Table 11. Non-invasive Helicobacter Pylori Diagnostic Market Drivers

Table 12. Non-invasive Helicobacter Pylori Diagnostic Market Challenges

Table 13. Non-invasive Helicobacter Pylori Diagnostic Market Restraints

Table 14. Global Non-invasive Helicobacter Pylori Diagnostic Revenue by Players (2019-2024) & (US$ Million)

Table 15. Global Non-invasive Helicobacter Pylori Diagnostic Market Share by Players (2019-2024)

Table 16. Global Top Non-invasive Helicobacter Pylori Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-invasive Helicobacter Pylori Diagnostic as of 2023)

Table 17. Ranking of Global Top Non-invasive Helicobacter Pylori Diagnostic Companies by Revenue (US$ Million) in 2023

Table 18. Global 5 Largest Players Market Share by Non-invasive Helicobacter Pylori Diagnostic Revenue (CR5 and HHI) & (2019-2024)

Table 19. Key Players Headquarters and Area Served

Table 20. Key Players Non-invasive Helicobacter Pylori Diagnostic Product Solution and Service

Table 21. Date of Enter into Non-invasive Helicobacter Pylori Diagnostic Market

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Non-invasive Helicobacter Pylori Diagnostic Market Size by Type (2019-2024) & (US$ Million)

Table 24. Global Non-invasive Helicobacter Pylori Diagnostic Revenue Market Share by Type (2019-2024)

Table 25. Global Non-invasive Helicobacter Pylori Diagnostic Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 26. Global Non-invasive Helicobacter Pylori Diagnostic Revenue Market Share by Type (2025-2030)

Table 27. Global Non-invasive Helicobacter Pylori Diagnostic Market Size by Application (2019-2024) & (US$ Million)

Table 28. Global Non-invasive Helicobacter Pylori Diagnostic Revenue Market Share by Application (2019-2024)

Table 29. Global Non-invasive Helicobacter Pylori Diagnostic Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 30. Global Non-invasive Helicobacter Pylori Diagnostic Revenue Market Share by Application (2025-2030)

Table 31. North America Non-invasive Helicobacter Pylori Diagnostic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 32. North America Non-invasive Helicobacter Pylori Diagnostic Market Size by Country (2019-2024) & (US$ Million)

Table 33. North America Non-invasive Helicobacter Pylori Diagnostic Market Size by Country (2025-2030) & (US$ Million)

Table 34. Europe Non-invasive Helicobacter Pylori Diagnostic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 35. Europe Non-invasive Helicobacter Pylori Diagnostic Market Size by Country (2019-2024) & (US$ Million)

Table 36. Europe Non-invasive Helicobacter Pylori Diagnostic Market Size by Country (2025-2030) & (US$ Million)

Table 37. Asia-Pacific Non-invasive Helicobacter Pylori Diagnostic Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 38. Asia-Pacific Non-invasive Helicobacter Pylori Diagnostic Market Size by Region (2019-2024) & (US$ Million)

Table 39. Asia-Pacific Non-invasive Helicobacter Pylori Diagnostic Market Size by Region (2025-2030) & (US$ Million)

Table 40. Latin America Non-invasive Helicobacter Pylori Diagnostic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 41. Latin America Non-invasive Helicobacter Pylori Diagnostic Market Size by Country (2019-2024) & (US$ Million)

Table 42. Latin America Non-invasive Helicobacter Pylori Diagnostic Market Size by Country (2025-2030) & (US$ Million)

Table 43. Middle East & Africa Non-invasive Helicobacter Pylori Diagnostic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Middle East & Africa Non-invasive Helicobacter Pylori Diagnostic Market Size by Country (2019-2024) & (US$ Million)

Table 45. Middle East & Africa Non-invasive Helicobacter Pylori Diagnostic Market Size by Country (2025-2030) & (US$ Million)

Table 46. Sekisui Diagnostics Company Detail

Table 47. Sekisui Diagnostics Business Overview

Table 48. Sekisui Diagnostics Non-invasive Helicobacter Pylori Diagnostic Product

Table 49. Sekisui Diagnostics Revenue in Non-invasive Helicobacter Pylori Diagnostic Business (2019-2024) & (US$ Million)

Table 50. Sekisui Diagnostics Recent Development

Table 51. F. Hoffmann-La Roche Company Detail

Table 52. F. Hoffmann-La Roche Business Overview

Table 53. F. Hoffmann-La Roche Non-invasive Helicobacter Pylori Diagnostic Product

Table 54. F. Hoffmann-La Roche Revenue in Non-invasive Helicobacter Pylori Diagnostic Business (2019-2024) & (US$ Million)

Table 55. F. Hoffmann-La Roche Recent Development

Table 56. Medline Industries Company Detail

Table 57. Medline Industries Business Overview

Table 58. Medline Industries Non-invasive Helicobacter Pylori Diagnostic Product

Table 59. Medline Industries Revenue in Non-invasive Helicobacter Pylori Diagnostic Business (2019-2024) & (US$ Million)

Table 60. Medline Industries Recent Development

Table 61. Meridian Bioscience Company Detail

Table 62. Meridian Bioscience Business Overview

Table 63. Meridian Bioscience Non-invasive Helicobacter Pylori Diagnostic Product

Table 64. Meridian Bioscience Revenue in Non-invasive Helicobacter Pylori Diagnostic Business (2019-2024) & (US$ Million)

Table 65. Meridian Bioscience Recent Development

Table 66. Bio-Rad Laboratories Company Detail

Table 67. Bio-Rad Laboratories Business Overview

Table 68. Bio-Rad Laboratories Non-invasive Helicobacter Pylori Diagnostic Product

Table 69. Bio-Rad Laboratories Revenue in Non-invasive Helicobacter Pylori Diagnostic Business (2019-2024) & (US$ Million)

Table 70. Bio-Rad Laboratories Recent Development

Table 71. Thermo Fisher Scientific Company Detail

Table 72. Thermo Fisher Scientific Business Overview

Table 73. Thermo Fisher Scientific Non-invasive Helicobacter Pylori Diagnostic Product

Table 74. Thermo Fisher Scientific Revenue in Non-invasive Helicobacter Pylori Diagnostic Business (2019-2024) & (US$ Million)

Table 75. Thermo Fisher Scientific Recent Development

Table 76. Alpha Laboratories Company Detail

Table 77. Alpha Laboratories Business Overview

Table 78. Alpha Laboratories Non-invasive Helicobacter Pylori Diagnostic Product

Table 79. Alpha Laboratories Revenue in Non-invasive Helicobacter Pylori Diagnostic Business (2019-2024) & (US$ Million)

Table 80. Alpha Laboratories Recent Development

Table 81. EKF Diagnostics Company Detail

Table 82. EKF Diagnostics Business Overview

Table 83. EKF Diagnostics Non-invasive Helicobacter Pylori Diagnostic Product

Table 84. EKF Diagnostics Revenue in Non-invasive Helicobacter Pylori Diagnostic Business (2019-2024) & (US$ Million)

Table 85. EKF Diagnostics Recent Development

Table 86. Quidel Company Detail

Table 87. Quidel Business Overview

Table 88. Quidel Non-invasive Helicobacter Pylori Diagnostic Product

Table 89. Quidel Revenue in Non-invasive Helicobacter Pylori Diagnostic Business (2019-2024) & (US$ Million)

Table 90. Quidel Recent Development

Table 91. Halyard Health Company Detail

Table 92. Halyard Health Business Overview

Table 93. Halyard Health Non-invasive Helicobacter Pylori Diagnostic Product

Table 94. Halyard Health Revenue in Non-invasive Helicobacter Pylori Diagnostic Business (2019-2024) & (US$ Million)

Table 95. Halyard Health Recent Development

Table 96. Cardinal Health Company Detail

Table 97. Cardinal Health Business Overview

Table 98. Cardinal Health Non-invasive Helicobacter Pylori Diagnostic Product

Table 99. Cardinal Health Revenue in Non-invasive Helicobacter Pylori Diagnostic Business (2019-2024) & (US$ Million)

Table 100. Cardinal Health Recent Development

Table 101. Beckman Coulter Company Detail

Table 102. Beckman Coulter Business Overview

Table 103. Beckman Coulter Non-invasive Helicobacter Pylori Diagnostic Product

Table 104. Beckman Coulter Revenue in Non-invasive Helicobacter Pylori Diagnostic Business (2019-2024) & (US$ Million)

Table 105. Beckman Coulter Recent Development

Table 106. Agilent Technologies Company Detail

Table 107. Agilent Technologies Business Overview

Table 108. Agilent Technologies Non-invasive Helicobacter Pylori Diagnostic Product

Table 109. Agilent Technologies Revenue in Non-invasive Helicobacter Pylori Diagnostic Business (2019-2024) & (US$ Million)

Table 110. Agilent Technologies Recent Development

Table 111. Coris BioConcept Company Detail

Table 112. Coris BioConcept Business Overview

Table 113. Coris BioConcept Non-invasive Helicobacter Pylori Diagnostic Product

Table 114. Coris BioConcept Revenue in Non-invasive Helicobacter Pylori Diagnostic Business (2019-2024) & (US$ Million)

Table 115. Coris BioConcept Recent Development

Table 116. Research Programs/Design for This Report

Table 117. Key Data Information from Secondary Sources

Table 118. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Non-invasive Helicobacter Pylori Diagnostic Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Non-invasive Helicobacter Pylori Diagnostic Market Share by Type: 2023 VS 2030

Figure 3. Invasive Techniques Features

Figure 4. Non-invasive Techniques Features

Figure 5. Global Non-invasive Helicobacter Pylori Diagnostic Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 6. Global Non-invasive Helicobacter Pylori Diagnostic Market Share by Application: 2023 VS 2030

Figure 7. Hospitals and Clinics Case Studies

Figure 8. Diagnostic Laboratories Case Studies

Figure 9. Non-invasive Helicobacter Pylori Diagnostic Report Years Considered

Figure 10. Global Non-invasive Helicobacter Pylori Diagnostic Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 11. Global Non-invasive Helicobacter Pylori Diagnostic Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 12. Global Non-invasive Helicobacter Pylori Diagnostic Market Share by Region: 2023 VS 2030

Figure 13. Global Non-invasive Helicobacter Pylori Diagnostic Market Share by Players in 2023

Figure 14. Global Top Non-invasive Helicobacter Pylori Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-invasive Helicobacter Pylori Diagnostic as of 2023)

Figure 15. The Top 10 and 5 Players Market Share by Non-invasive Helicobacter Pylori Diagnostic Revenue in 2023

Figure 16. North America Non-invasive Helicobacter Pylori Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 17. North America Non-invasive Helicobacter Pylori Diagnostic Market Share by Country (2019-2030)

Figure 18. United States Non-invasive Helicobacter Pylori Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 19. Canada Non-invasive Helicobacter Pylori Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. Europe Non-invasive Helicobacter Pylori Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. Europe Non-invasive Helicobacter Pylori Diagnostic Market Share by Country (2019-2030)

Figure 22. Germany Non-invasive Helicobacter Pylori Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. France Non-invasive Helicobacter Pylori Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. U.K. Non-invasive Helicobacter Pylori Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Italy Non-invasive Helicobacter Pylori Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Russia Non-invasive Helicobacter Pylori Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Nordic Countries Non-invasive Helicobacter Pylori Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Asia-Pacific Non-invasive Helicobacter Pylori Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Asia-Pacific Non-invasive Helicobacter Pylori Diagnostic Market Share by Region (2019-2030)

Figure 30. China Non-invasive Helicobacter Pylori Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Japan Non-invasive Helicobacter Pylori Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. South Korea Non-invasive Helicobacter Pylori Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Southeast Asia Non-invasive Helicobacter Pylori Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. India Non-invasive Helicobacter Pylori Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Australia Non-invasive Helicobacter Pylori Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Latin America Non-invasive Helicobacter Pylori Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Latin America Non-invasive Helicobacter Pylori Diagnostic Market Share by Country (2019-2030)

Figure 38. Mexico Non-invasive Helicobacter Pylori Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Brazil Non-invasive Helicobacter Pylori Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Middle East & Africa Non-invasive Helicobacter Pylori Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Middle East & Africa Non-invasive Helicobacter Pylori Diagnostic Market Share by Country (2019-2030)

Figure 42. Turkey Non-invasive Helicobacter Pylori Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Saudi Arabia Non-invasive Helicobacter Pylori Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Sekisui Diagnostics Revenue Growth Rate in Non-invasive Helicobacter Pylori Diagnostic Business (2019-2024)

Figure 45. F. Hoffmann-La Roche Revenue Growth Rate in Non-invasive Helicobacter Pylori Diagnostic Business (2019-2024)

Figure 46. Medline Industries Revenue Growth Rate in Non-invasive Helicobacter Pylori Diagnostic Business (2019-2024)

Figure 47. Meridian Bioscience Revenue Growth Rate in Non-invasive Helicobacter Pylori Diagnostic Business (2019-2024)

Figure 48. Bio-Rad Laboratories Revenue Growth Rate in Non-invasive Helicobacter Pylori Diagnostic Business (2019-2024)

Figure 49. Thermo Fisher Scientific Revenue Growth Rate in Non-invasive Helicobacter Pylori Diagnostic Business (2019-2024)

Figure 50. Alpha Laboratories Revenue Growth Rate in Non-invasive Helicobacter Pylori Diagnostic Business (2019-2024)

Figure 51. EKF Diagnostics Revenue Growth Rate in Non-invasive Helicobacter Pylori Diagnostic Business (2019-2024)

Figure 52. Quidel Revenue Growth Rate in Non-invasive Helicobacter Pylori Diagnostic Business (2019-2024)

Figure 53. Halyard Health Revenue Growth Rate in Non-invasive Helicobacter Pylori Diagnostic Business (2019-2024)

Figure 54. Cardinal Health Revenue Growth Rate in Non-invasive Helicobacter Pylori Diagnostic Business (2019-2024)

Figure 55. Beckman Coulter Revenue Growth Rate in Non-invasive Helicobacter Pylori Diagnostic Business (2019-2024)

Figure 56. Agilent Technologies Revenue Growth Rate in Non-invasive Helicobacter Pylori Diagnostic Business (2019-2024)

Figure 57. Coris BioConcept Revenue Growth Rate in Non-invasive Helicobacter Pylori Diagnostic Business (2019-2024)

Figure 58. Bottom-up and Top-down Approaches for This Report

Figure 59. Data Triangulation

Figure 60. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Mumps Vaccine Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-19C11605

Tue Jun 18 00:00:00 UTC 2024

Add to Cart

Global Monkeypox Vaccine Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-17F11344

Tue Jun 18 00:00:00 UTC 2024

Add to Cart

Global Coxsackie Virus A16 Nucleic Acid Detection Reagent Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-20I10733

Wed Jun 12 00:00:00 UTC 2024

Add to Cart

Global Hepatitis B Virus Nucleic Acid Detection Kit Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-38W10575

Wed Jun 12 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions